SCHEMBL2169972

SCHEMBL2169972

COc1ccc(C(CC=O)CC=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
ALDH1A1 P00352 4/20 0.47
CYP2A6 P11509 1/20 0.47
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
FFAR1 O14842 1/20 0.41
HTT P42858 1/20 0.41
ACP3 P15309 1/20 0.41
AOC3 Q16853 1/20 0.41
SLC2A1 P11166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21988157 0.91 FFAR1 (0.48) L3MBTL1ALDH1A1CYP2A6CA12CA1
SCHEMBL22562811 0.89 ALDH1A1 (0.45) L3MBTL1ALDH1A1CYP2A6CA12CA1
SCHEMBL7229107 0.84 ALDH1A1 (0.47) L3MBTL1ALDH1A1CYP2A6CA12CA1
SCHEMBL27746044 0.84 SERPINH1 (0.48) L3MBTL1ALDH1A1CYP2A6CYP1A2CYP2D6
SCHEMBL27746039 0.84 SERPINH1 (0.48) L3MBTL1ALDH1A1CYP2A6CYP1A2CYP2D6
SCHEMBL25336328 0.82 NR1I2 (0.43) L3MBTL1ALDH1A1SLC2A1
SCHEMBL809634 0.82 L3MBTL1 (0.67) L3MBTL1ALDH1A1CA1CA2TDP1
SCHEMBL812999 0.82 L3MBTL1 (0.67) L3MBTL1ALDH1A1CA1CA2TDP1
SCHEMBL2634023 0.81 AOC3 (0.54) L3MBTL1ALDH1A1CYP2A6CA12CA1
SCHEMBL9715531 0.81 AOC3 (0.53) L3MBTL1ALDH1A1CYP2A6CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346863-A2 N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS Elan Pharmaceuticals Inc. (US) 2011-07-27 EP disclosed
WO-2010028213-A2 N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 2010-03-11 WO disclosed
EP-1372703-A2 MATRIX STABILIZED ENZYME CRYSTALS AND METHODS OF USE IBEX TECHNOLOGIES (CA) 2004-01-02 EP disclosed
US-20020182201-A1 Matrix stabilized enzyme crystals and methods of use BIOMARIN PHARMACEUTICAL INC. 2002-12-05 US disclosed
WO-2002070646-A2 MATRIX STABILIZED ENZYME CRYSTALS AND METHODS OF USE IBEX TECHNOLOGIES (US) 2002-09-12 WO disclosed
US-4742068-A Dihydropyridine compounds having 1,4,4-trisubstitution useful as antihypertensive agents MCNEILAB, INC. (US) 1988-05-03 US disclosed